Annual Drug Patent Expirations for NAFTIN
Naftin is a drug marketed by Sebela Ireland Ltd and is included in three NDAs. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.
This drug has three patent family members in three countries.
The generic ingredient in NAFTIN is naftifine hydrochloride. Two suppliers are listed for this compound. Additional details are available on the naftifine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
